Pages that link to "Q41694692"

The following pages link to Causes and consequences of the loss of serotonergic presynapses elicited by the consumption of 3,4-methylenedioxymethamphetamine (MDMA, ?ecstasy?) and its congeners (Q41694692):

Displaying 44 items.

• The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs (Q28361466) (← links)
• A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on dopamine neurones in mouse brain (Q28366048) (← links)
• The Neuropsychopharmacology and Toxicology of 3,4-methylenedioxy-N-ethyl-amphetamine (MDEA). (Q30341737) (← links)
• Cortisol and 3,4-methylenedioxymethamphetamine: neurohormonal aspects of bioenergetic stress in ecstasy users (Q30478967) (← links)
• Ecstasy: are animal data consistent between species and can they translate to humans? (Q31033315) (← links)
• Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain (Q31561882) (← links)
• White-matter abnormalities in brain during early abstinence from methamphetamine abuse (Q33643608) (← links)
• Genotype effects on neurodegeneration and neuroadaptation in monoaminergic neurotransmitter systems (Q33952958) (← links)
• Role of serotonin and/or norepinephrine in the MDMA-induced increase in extracellular glucose and glycogenolysis in the rat brain (Q34150103) (← links)
• Short- and long-term effects of MDMA (“ecstasy”) on synaptosomal and vesicular uptake of neurotransmitters in vitro and ex vivo (Q34196259) (← links)
• Serotonergic dysfunction, negative mood states, and response to alcohol (Q34236249) (← links)
• Human psychobiology of MDMA or 'Ecstasy': an overview of 25 years of empirical research (Q34359604) (← links)
• Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research (Q34528465) (← links)
• Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity (Q34558842) (← links)
• Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk (Q34647657) (← links)
• Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress (Q35153738) (← links)
• A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities (Q35607159) (← links)
• MDMA (3,4-Methylenedioxymethamphetamine) or ecstasy: the neuropsychobiological implications of taking it at dances and raves (Q35946697) (← links)
• Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy (Q36020276) (← links)
• MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress (Q36410784) (← links)
• Serotonergic dysfunction: brain imaging and behavioral correlates (Q36547548) (← links)
• Dance clubbing on MDMA and during abstinence from Ecstasy/MDMA: prospective neuroendocrine and psychobiological changes (Q36617655) (← links)
• The psychotherapeutic potential of MDMA (3,4-methylenedioxymethamphetamine): an evidence-based review (Q36734781) (← links)
• Cannabis and Ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users (Q36829594) (← links)
• Saturday night fever in ecstasy/MDMA dance clubbers: Heightened body temperature and associated psychobiological changes (Q37226589) (← links)
• Review: The neuropathology of drug abuse. (Q37800120) (← links)
• MDMA and heightened cortisol: a neurohormonal perspective on the pregnancy outcomes of mothers used 'Ecstasy' during pregnancy. (Q38178521) (← links)
• Recreational 3,4-methylenedioxymethamphetamine or 'ecstasy': Current perspective and future research prospects. (Q38665183) (← links)
• The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance. (Q40360036) (← links)
• Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat. (Q40602429) (← links)
• Neurocognitive impairments in MDMA and other drug users: MDMA alone may not be a cognitive risk factor (Q43096892) (← links)
• Enhancement of 3,4-methylenedioxymethamphetamine neurotoxicity by the energy inhibitor malonate (Q43572918) (← links)
• CB1 cannabinoid receptor-mediated neurite remodeling in mouse neuroblastoma N1E-115 cells (Q43700690) (← links)
• Reduced (+/-)-3,4-methylenedioxymethamphetamine ("Ecstasy") metabolism with cytochrome P450 2D6 inhibitors and pharmacogenetic variants in vitro. (Q44057989) (← links)
• Effect of sulpiride on the amphetamine-induced changes in extracellular dopamine, DOPAC, and hydroxyl radical generation in the rat striatum (Q44496554) (← links)
• Involvement of the brain serotonergic system in the locomotor stimulant effects of chlorpheniramine in Wistar rats: implication of postsynaptic 5-HT1A receptors (Q44698544) (← links)
• Intended and unintended use of cathinone mixtures (Q48211628) (← links)
• Oxidative stress in rat retina and hippocampus after chronic MDMA ('ecstasy') administration. (Q48221127) (← links)
• The impact of recreational MDMA 'ecstasy' use on global form processing. (Q48593735) (← links)
• Is the recreational use of 3,4-methylenedioxy-methamphetamine safe? (Q50127081) (← links)
• Dancing hot on Ecstasy: physical activity and thermal comfort ratings are associated with the memory and other psychobiological problems reported by recreational MDMA users. (Q51980841) (← links)
• Serotonergic deficits and impaired passive-avoidance learning in rats by MDEA: a comparison with MDMA. (Q52170975) (← links)
• Rapid and transient inhibition of mitochondrial function following methamphetamine or 3,4-methylenedioxymethamphetamine administration (Q73901664) (← links)
• Synthetic psychoactive cathinones: hypothermia and reduced lethality compared to methamphetamine and methylenedioxymethamphetamine (Q89728368) (← links)